A listed star of our MedTech 50 ranking in 2022 has appointed a new chair. BiVictriX Therapeutics, which is aiming to transform the design of cancer drugs, said Dr Michael Kauffman will replace Iain Ross as non-executive chairman.  Ross will continue as a non-executive director on the BiVictriX board but steps down as chair due … Continue reading Listed MedTech 50 firm appoints new chair